Carmen Spinney, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3001 Woodward Ave., Lock Haven, PA 17745 Phone: 570-753-5000 Fax: 570-753-3475 |
Dr. Charles V Ackley, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 955 Bellefonte Ave, Lock Haven, PA 17745 Phone: 570-748-7714 Fax: 570-893-6325 |
Pravinchandra G. Chapla, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Outlet Ln Ste 380, Lock Haven, PA 17745 Phone: 570-398-1800 Fax: 570-398-3320 |
Jerome Keefer Ellis, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 24 Cree Dr, Lock Haven, PA 17745 Phone: 570-893-5000 |
Aaron D Simms, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Cree Dr, Lock Haven, PA 17745 Phone: 570-893-5040 |
Dr. Joseph Timothy Candelore Jr., D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 955 Bellefonte Ave, Lock Haven, PA 17745 Phone: 570-748-7714 Fax: 570-893-6325 |
Taylor Talasky, PA-C Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 311 Center St Apt 2, Lock Haven, PA 17745 Phone: 716-499-9517 |
News Archive
Of the 2.3 million inmates crowding our nation's prisons and jails, 1.5 million meet the DSM IV medical criteria for substance abuse or addiction, and another 458,000, while not meeting the strict DSM IV criteria, had histories of substance abuse; were under the influence of alcohol or other drugs at the time of their crime; committed their offense to get money to buy drugs; were incarcerated for an alcohol or drug law violation; or shared some combination of these characteristics, according to Behind Bars II: Substance Abuse and America's Prison Population. Combined these two groups constitute 85 percent of the U.S. prison population.
Stalking is a widely recognized public health concern, yet little information is available about stalking behaviors among teenage victims.
Chelsea Therapeutics International, Ltd. has completed its previously announced public offering of common stock and announced that the underwriters exercised their option to purchase approximately 1.07 million additional shares to cover over-allotments.
Paragonix Technologies, Inc. today announced that it has successfully completed filing of a Pre-Marketing Notification Application (510(k)) with the US Food and Drug Administration for its Sherpa Pak Transporter. The Sherpa Pak Transporter is indicated for the static hypothermic preservation of kidneys during transportation and eventual transplantation into a recipient, using cold storage solutions indicated for use with the kidney.
› Verified 2 days ago